Since the initial localisation ofa gene defect to the long arm of chromosome 3 in a family with autosomal dominant retinitis pigmentosa,' numerous mutations in the rhodopsin gene have been described. The first was a cytosine to adenine transversion in codon 23 resulting in a proline to histidine substitution.2 A large number of different rhodopsin mutations have now been identified. `8 To date, the clinical features of autosomal dominant retinitis pigmentosa families with nine different rhodopsin amino acid substitutions or deletions have been reported.9'7 Both quantitative and qualitative differences have been recorded with different rhodopsin mutations. In 1991, Keen and 
Materials and methods

SUBJECTS
The proband IV-7 was identified by a British
Retinitis Pigmentosa Society questionnaire. The complete kindred is shown in Figure 1 . Six generations were documented with approximately 50% of those at risk of having the abnormal gene being affected in each generation, males and females were affected equally, and there was male to male transmission. These findings implied autosomal dominant inheritance with complete penetrance. In August 1990 all available family members were reviewed (Table 1) . Each affected family member had an ocular examination including visual acuity, confrontation visual fields, and indirect ophthalmoscopy. All affected members had typical fundus features of retinitis pigmentosa: optic nerve pallor, retinal vascular attenuation, and peripheral neurosensory retinal pigmentation with macular sparing. After the examinations were completed, 10 ml of peripheral blood were taken from each person and placed in potassium ethylenediaminetetra-acetic acid. Blood samples were taken from 10 affected and five unaffected family members, as well as one spouse. Details of the DNA analysis have been published in a separate report.7
The functional loss was characterised in four affected family members with a visual acuity of 6/60 or better using the following techniques:
(1) Photopic visual Jields. Kinetic Goldmann visual fields or Humphrey visual fields were performed in the standard fashion.
(2) Dark adapted visual fields. The pupil was dilated with phenylephrine 2 5% and cyclopentolate 1 0%, and the patient was dark adapted for at least 45 minutes. The Humphrey field analyser (Allergan Humphrey, Hertfordshire) was modified for use in dark adapted conditions.'9 An infrared source illuminated the bowl, and an infrared monitor (Phillips, Eindhoven, Holland) was used to detect eye movements. Fields were Owens, Fitzke, Ingleheam, jay, Keen, Arden, Bhattacharya, Bird (4) Fundus reflectometty. Fundus reflectometry was used to measure reflectance levels ofthe light adapted eye compared with the dark adapted eye using published methods. 22 This provided a quantitative estimate of rhodopsin regeneration.
(5) Electroretinography. In patients IV-8, IV-1, and IV-12, the electroretinogram was obtained with silver-silver chloride reference and ground electrodes, a gold foil electrode placed in the lower fornix, and a stroboscopic flash (Table 3 ).
Dark adaptometry was tested at coordinates 3,3 and 3,-3. Prebleach thresholds to the V target were elevated to 24 dB and 25 dB, respectively. A normal cone portion of the dark adaptometry curve was found; prebleach thresholds were reached in 10 minutes (Fig 2) . Dark adaptometry was continued for 30 minutes.
There was no cone-rod break and no identifiable rod portion (Table 3 ).
The ERG showed no recordable response. CASE 4 Family member V-7, aged 18 years, was of particular interest to us. At the time ofthe family survey, he denied symptoms. On repeat questioning he reported some difficulty at night but to a lesser degree than the rest of his family. He denied loss of side vision or daytime visual difficulty. He had worn hyperopic spectacle correction since the age of6 years, and amblyopia of the left eye was diagnosed aged 6 years which had been treated by patching of the right eye.
On examination, visual acuity with +4 50 spectacles was 6/6 with the right eye and 6/9 with the left. There was a variable 8°to 120 left esotropia. No cataracts were present. There were many vitreous cells. The fundus showed mild optic nerve pallor and retinal vascular attenuation. There was limited pigment migration into the retina and widespread white subretinal deposits (Fig 3) . No cystoid macular oedema or central choroidal atrophy was seen.
Light adapted central 30-2 and peripheral 30/60-2 fields were performed in the right eye with the V white target. They were relatively full except for nasal depression between 400 and 600 (Fig 4 A-D, Table 3 ).
Right eye central 30-2 dark adapted red fields showed wide-spread diffuse depression. Mean sensitivity values obtained were 20 dB at 30 and 8 dB at 90 (Fig 4 E, F) . Central 30-2 and peripheral 30/60-2 dark adapted blue field showed no response throughout, with the exception of the central 30 which showed a mean value of 10 dB (Fig 4 G H, Table 3 ). Reliability indices were excellent.
Pre-bleach dark adaptometry thresholds to the V target at points 3,-3 and -9,-9 were 45 dB at Colour vision testing of the right eye showed normal thresholds within the central 10; outside I' the thresholds were elevated. Testing at 100 showed absent tritan colour vision and gross changes along other colour confusion lines.
Discussion
The lysine-296-glutamic acid mutation in the rhodopsin gene causes a severe form of retinitis pigmentosa. All patients had a lifetime of poor night vision. There was relative sparing of daytime vision early in the disease, a feature characteristic of type I or diffuse retinitis pigmentosa.2 " By the fourth decade of life there was reduction ofcentral vision, severe visual field constriction, and lens opacification. Although the visual prognosis was universally poor, some variability ofdisease expression was detected as is common in autosomal dominant disease. The disease is more severe than that seen with the mutations glutamic acid-344-stop, arginine-135-leucine and arginine-135-tryptophan, and lacks the altitudinal distribution of disease seen with 
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